Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669850 · ClinicalTrials.gov registry record · NA
Clipped Versus Handsewn Arteriovenous Fistula Anastomosis
A NA study, sponsored by Gundersen Lutheran Medical Foundation.
- Terminated
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT01669850: Clinical Trial NA study, sponsored by Gundersen Lutheran Medical Foundation.
NCT01669850 is a NA study that was terminated before completion, run by Gundersen Lutheran Medical Foundation. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01669850, a NA study, was terminated before completion, sponsored by Gundersen Lutheran Medical Foundation.
- TERMINATED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether handsewn anastomosis versus clipped technique is associated with more complications, fistula failures, surgical cost and surgical time.
Primary Outcome
Patency will be assessed and the fistula considered patent if it has been accessed for dialysis at least once, or based on clinical assessment with palpable thrill if dialysis access has not been attempted.
Interventions
- DEVICE Clipped anastomosis
- PROCEDURE Handsewn anastomosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
Why NCT01669850 stopped before completion
NCT01669850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Clipped anastomosis is the first listed.
NCT01669850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01669850 about?
NCT01669850 is a clinical study titled "Clipped Versus Handsewn Arteriovenous Fistula Anastomosis". The purpose of this study is to determine whether handsewn anastomosis versus clipped technique is associated with more complications, fistula failures, surgical cost and surgical time.
What is the current status of trial NCT01669850?
This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2012-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01669850?
The interventions under investigation include: Clipped anastomosis (DEVICE), Handsewn anastomosis (PROCEDURE).
Who is sponsoring clinical trial NCT01669850?
This trial is sponsored by Gundersen Lutheran Medical Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01669850's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia